---
figid: PMC6851521__bsr-39-bsr20192453-g1
figtitle: Molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC6851521
filename: bsr-39-bsr20192453-g1.jpg
figlink: /pmc/articles/PMC6851521/figure/F1/
number: F1
caption: On the one hand, several LncRNAs (green) regulate PKM2 expression via affecting
  cell signaling pathways (blue). (1) HULC and LincRNA-p21 activate the PI3K/AKT/mTOR
  pathway in human liver cancer by inhibiting the expression of PTEN and PKM2. Furthermore,
  LINC01554 down-regulation empowers cancer cells acquiring high aerobic glycolysis
  via regulating PKM2 and Akt/mTOR signaling pathway. (2) LincRNA-p21 negatively regulated
  aerobic glycolysis independent of p53 signaling. (3) MEG3 regulates genes in the
  TGF-β pathway by forming RNA–DNA triple structures. In additional, PKM2 knockdown
  increases the expression of the TGF-β1 gene in HCC cells. MEG3 promotes the expression
  and maturation of miR122 which targets PKM2. On the other hand, several LncRNAs
  such as HULC, MEG3, lincROR, MAFG-ASI and LINC00689 regulate PKM2 expression by
  targeting miRNAs (gray).
papertitle: The molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism.
reftext: Ting Tao, et al. Biosci Rep. 2019 Nov 29;39(11):BSR20192453.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9515384
figid_alias: PMC6851521__F1
figtype: Figure
redirect_from: /figures/PMC6851521__F1
ndex: 429af4b8-def0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6851521__bsr-39-bsr20192453-g1.html
  '@type': Dataset
  description: On the one hand, several LncRNAs (green) regulate PKM2 expression via
    affecting cell signaling pathways (blue). (1) HULC and LincRNA-p21 activate the
    PI3K/AKT/mTOR pathway in human liver cancer by inhibiting the expression of PTEN
    and PKM2. Furthermore, LINC01554 down-regulation empowers cancer cells acquiring
    high aerobic glycolysis via regulating PKM2 and Akt/mTOR signaling pathway. (2)
    LincRNA-p21 negatively regulated aerobic glycolysis independent of p53 signaling.
    (3) MEG3 regulates genes in the TGF-β pathway by forming RNA–DNA triple structures.
    In additional, PKM2 knockdown increases the expression of the TGF-β1 gene in HCC
    cells. MEG3 promotes the expression and maturation of miR122 which targets PKM2.
    On the other hand, several LncRNAs such as HULC, MEG3, lincROR, MAFG-ASI and LINC00689
    regulate PKM2 expression by targeting miRNAs (gray).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HULC
  - TP53COR1
  - PTEN
  - MIR372
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TP63
  - HCP5
  - ZNF398
  - H3P41
  - MTOR
  - TGFB1
  - TGFB2
  - TGFB3
  - LINC00689
  - PKM
  - PKLR
  - TP53TG1
  - MAFG-AS1
  - MILIP
  - STAT3
  - BAS
  - LINC-ROR
  - FEZF1-AS1
  - MEG3
  - NIBAN2
  - MIR122
  - Trp53cor1
  - Pten
  - Akt1
  - Pik3r1
  - Mtor
  - Tgfb1
  - Ltbp1
  - Pkm
  - Stat3
  - Bas
  - Meg3
  - Niban2
  - Mir122
  - Pik3cg
  - ptenb
  - mtor
  - pkma
  - stat3
  - mir122
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Tor
  - dpp
  - gbb
  - put
  - mav
  - mir-124
  - as
  - bas
  - para
  - pyd3
---
